Pharma Commercial Mock
IQVIA™
Connected Intelligence™
National Prescription Audit
Source: NPA Weekly · Refresh: 2026-10-30·Marten Veskimae
Brand-level trends · ZENVARA™

Weekly NPA dashboard · national

TRx (week)
2,037▲ 11.9%
vs WK29, 2026-10-30
NRx (week)
586▲ 8.1%
vs prior week
NBRx (week)
120▲ 6.2%
new-to-brand
Cumulative TRx
24,445
12-week window
📈TRx — plan vs actual
09161,8332,74908-1408-2809-1109-2510-0910-23
Plan Actual
📊NRx ⨉ NBRx trend
08-1408-2809-1109-2510-0910-23
NRx NBRx
🍩Channel mix
RETAIL32%MAIL60%LTC8%
🗺️Geography — variance vs plan
WestMidwestNortheastSoutheast
Variance vs plan — darker = worse. Northeast highlighted as primary deviation region.
Weekly detail · 12 weeks
Week EndingTRxNRxNBRxPlan TRxVar %Cum TRx
2026-08-142,1506331582,479-13.3%2,150
2026-08-212,0576331572,483-17.2%4,207
2026-08-282,0336051492,487-18.3%6,240
2026-09-042,2266931642,490-10.6%8,466
2026-09-111,9615841402,492-21.3%10,427
2026-09-181,9946051442,494-20.0%12,421
2026-09-252,1876311402,495-12.3%14,608
2026-10-021,8745401212,496-24.9%16,482
2026-10-092,1256241442,497-14.9%18,607
2026-10-161,9805921222,498-20.7%20,587
2026-10-231,8215421132,498-27.1%22,408
2026-10-302,0375861202,499-18.5%24,445
© 2026 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union and various other countries. NPA™, Xponent™ and Connected Intelligence™ are trademarks of IQVIA Inc. This view is a demo mock and is not affiliated with IQVIA.